医学
感染性休克
去甲肾上腺素
死亡率
休克(循环)
麻醉
重症监护医学
急诊医学
败血症
内科学
多巴胺
作者
Ryota Sato,Abhijit Duggal,Gretchen L. Sacha,Michael Rudoni,Angel Coz Yataco,Ashish K. Khanna,Siddharth Dugar
出处
期刊:Chest
[Elsevier]
日期:2022-07-31
卷期号:163 (1): 148-151
被引量:11
标识
DOI:10.1016/j.chest.2022.07.018
摘要
The reported mortality rate of septic shock is 30% to 40%. 1 Bauer M. Gerlach H. Vogelmann T. Preissing F. Stiefel J. Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019: results from a systematic review and meta-analysis. Critical Care. 2020; 24: 239 Crossref PubMed Scopus (150) Google Scholar However, these reported mortality rates do not take into consideration the severity of septic shock. There remains limited evidence on the prognosis of patients with septic shock whose condition requires higher doses of vasopressors. Although it is commonly perceived that higher doses of vasopressors translate into worsened clinical outcomes, the complex relationship between vasopressor dose and death has not been well-described. Therefore, we investigated the relationship between cumulative vasopressor dosage and in-hospital mortality rates in patients with septic shock.
科研通智能强力驱动
Strongly Powered by AbleSci AI